RNS Number : 5837U
Georgia Healthcare Group PLC
25 November 2019
London, 25 November 2019
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Bill Huyett
|
|
2.
|
Reason for the notification
|
|
a)
|
Position / status
|
Chairman, Georgia Healthcare Group PLC and PDMR
|
|
b)
|
Initial notification / amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Georgia Healthcare Group PLC
|
|
b)
|
LEI:
|
213800RJGJDDZENQER80
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification Code
|
ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
|
b)
|
Nature of the transaction
|
Purchase of ordinary shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
£1.778175
|
10,000
|
|
£1.691567
|
40,000
|
|
|
d)
|
Aggregated information
|
|
|
|
Aggregated volume
|
10,000 shares were acquired on 20 November 2019
40,000 shares were acquired on 21 November 2019
|
|
|
Aggregated price
|
20 November 2019: £17781.75
21 November 2019: £67662.68
|
|
|
|
|
|
e)
|
Date of the transactions
|
20 November 2019 and 21 November 2019
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
Name of authorised official of issuer responsible for making notification:
Link Company Matters Limited, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the
United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHLLFLELVLEFIA